New pill takes aim at Hard-to-Treat cancers
NCT ID NCT07593144
First seen May 22, 2026 · Last updated Jun 15, 2026 · Updated 7 times
Summary
This study tests an experimental daily pill, FS-207, in people with advanced solid tumors that have a specific DNA feature called MSI-H. The goal is to see if the drug is safe, how the body processes it, and whether it can shrink or control the cancer. About 156 adults whose cancer has worsened after standard treatments will take part.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMORS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Cancer Hospital of Shandong First Medical School
Jinan, Shandong, 250117, China
-
Fujian Cancer Hospital
Fuzhou, Fujian, 350014, China
-
General Hospital of Ningxia Medical University
Yinchuan, Ningxia, 750004, China
-
Guangdong Provincial People's Hospital
Guangzhou, Guangdong, 510080, China
-
Hunan Cancer Hospital
Changsha, Hunan, 410013, China
-
Jiangxi Cancer Hospital
Nanchang, Jiangxi, 330029, China
-
Jilin Cancer Hospital
Changchun, Jilin, 130012, China
-
Peking Union Medical College Hospital
Beijing, 100730, China
-
Peking University Cancer Hospital
Beijing, 100142, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Shanghai Tenth People's Hospital
Shanghai, 200072, China
-
The Affiliated Hospital of Qingdao University
Qingdao, Shandong, 266000, China
-
The First Affiliated Hospital of Anhui Medical University
Hefei, Anhui, China
-
The First Affiliated Hospital of China Medical University
Shenyang, Liaoning, 110001, China
-
The First Affiliated Hospital of Zhengzhou University
Zhengzhou, Henan, 450052, China
-
Tongji Hospital Affiliated to Tongji Medical College of Huazhong University of Science & Technology
Wuhan, Hubei, 430030, China
-
West China Hospital,Sichuan University
Chengdu, Sichuan, 610041, China
-
the Second Affiliated Hospital Zhejiang University School of Medicine
Hangzhou, Zhejiang, 310009, China
Conditions
Explore the condition pages connected to this study.